NeetaDPandit-TaskarMD

Nuclear Medicine • New York, NY

Member and Attending radiologist, Memorial Sloan Kettering and Professor, Radiology, Weill Cornell Medical College

Join to view full profile

Dr. Pandit-Taskar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pandit-Taskar's full profile

Already have an account?

Office
1275 York Ave
New York, NY 10065
Phone+1 212-639-7372

Education & Training

Memorial Sloan Kettering Cancer CenterResidency, Nuclear Medicine, 2000 - 2001
Icahn School of Medicine at Mount Sinai (NYC Health + Hospitals: Elmhurst)Internship, Transitional Year, 1995 - 1996
Icahn School of Medicine at Mount SinaiResidency, Nuclear Medicine, 1993 - 1995
Lady Hardinge Medical CollegeClass of 1990

Certifications & Licensure

NJ State Medical License 2006 - 2025
NY State Medical License 2001 - 2025
PA State Medical License 2024 - 2024
CT State Medical License 1997 - 2013
American Board of Nuclear Medicine Nuclear Medicine

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2013-2014
Top Doctors: New York Metro Area Castle Connolly, 2013-2014
New York Magazine: Top Doctors Castle Connolly, 2012-2014
America's Top Doctors for Cancer Castle Connolly, 2012-2013
Join now to see all

Clinical Trials

Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250 Start of enrollment: 2005 Jul 06
Completed
Phase 1
Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59) Start of enrollment: 1977 Jul 01
Completed
Phase 1
Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer. Start of enrollment: 2004 Jun 01
Completed
Early Phase 1
Phase I/IIA Study of PET Imaging With 89Zr-Df-IAB2M in Metastatic Prostate Cancer Start of enrollment: 2013 Aug 01
Completed
Phase 1, Phase 2
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma Start of enrollment: 2021 Feb 02
Recruiting
Early Phase 1
89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL) Start of enrollment: 2020 Sep 11
Active, not recruiting
Early Phase 1
Open-Label Study of 18F-mFBG for Imaging Neuroblastoma Start of enrollment: 2021 Nov 18
Active, not recruiting
Phase 3
Roles: Contact
CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma Start of enrollment: 2022 Mar 11
Recruiting
Phase 2
Roles: Contact
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma Start of enrollment: 2006 May 01
Recruiting
Phase 2
Roles: Contact
Study of a New Technique for Imaging Pancreatic Cancer Start of enrollment: 2021 May 10
Active, not recruiting
Phase 1
Roles: Contact, Principal Investigator
Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer Start of enrollment: 2022 Feb 16
Recruiting
Phase 2
Roles: Contact
Safety and Targeting of Anti-hk2 Antibody in mCRPC Start of enrollment: 2019 Sep 18
Terminated
Early Phase 1
Roles: Contact
PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9 Start of enrollment: 2023 Feb 10
Recruiting
Phase 1
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Safety observations in neuroblastoma patients undergoing 18F-mFBG PET.
Neeta Pandit-Taskar, Ellen Basu, Eloisa Balquin, P David Mozley, Arnold F Jacobson
Nuclear Medicine Communications. 2024-12-06
Craniospinal irradiation and/or intraventricular radioimmunotherapy after high-dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma-Sa...
Sameer Farouk Sait, Nancy A Kernan, Elizabeth Klein, Barbara Spitzer, Carolyn Fein Levy
Pediatric Blood & Cancer. 2024-11-01
Novel PET Imaging Techniques in the Management of Hematologic Malignancies.
Cristina Nanni, Paolo Castellucci, Stefano Fanti, Neeta Pandit-Taskar
PET Clinics. 2024-10-01

Press Mentions

SNMMI 2023 Annual Meeting Abstract of the Year Awarded to Actinium's Iomab-B Phase 3 SIERRA DataJune 27th, 2023